Oct 24, 2018 | Articles & Updates
On October 10, 2018, the Food and Drug Administration (FDA) issued a notice for public comment on the impact of drug scheduling on the availability of 16 substances for medical use, including cannabis, under the International Drug Scheduling; Convention on...